Vassileva, S., Murrell, D.F. , Culton, D.A. , Ujiie, H., Hertl, M., Goebeler, M., Sinha, A.A., Schmidt, E., Stoykov, I., Verheesen, P., Borradori, L., Werth, V.P. and Joly, P. 2024. Overview of Clinical Trials With Efgartigimod in Autoimmune Blistering Diseases: Pemphigus Vulgaris and Pemphigus Foliaceus (ADDRESS and ADDRESS+) and Bullous Pemphigoid (BALLAD and BALLAD+). SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s345. DOI:https://doi.org/10.25251/skin.8.supp.345.